Erratum: Lifetime history of depression predicts increased amyloid-β accumulation in patients with mild cognitive impairment (Journal of Alzheimer's Disease (2015) 45: 3 (907-919)) DOI: 10.3233/JAD-142931);Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment

Journal of Alzheimer's Disease

Volumn 45, Issue 3, 2015, Pages 907-919

  Chung, Jun Ku ^a,b   Plitman, Eric ^a,b   Nakajima, Shinichiro ^b,c,d   Chow, Tiffany W ^a,b,c   Chakravarty, M Mallar ^e,f   Caravaggio, Fernando ^a,b   Gerretsen, Philip ^b,c   Brown, Eric E ^b,c   Iwata, Yusuke ^b,d   Mulsant, Benoit H ^c   Graff Guerrero, Ariel ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d KEIO UNIVERSITY   (Japan)

^e DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; amyloid ; major depression; mild cognitive impairment; positron emission tomography

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETAPIR F 18; APOLIPOPROTEIN E4; FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BIOACCUMULATION; CARDIOVASCULAR RISK; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PET SCANNER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; BRAIN CORTEX; BRAIN MAPPING; COMPLICATION; DEPRESSION; FACTUAL DATABASE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PSYCHOLOGY; SCINTISCANNING;

AGED; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; BRAIN MAPPING; CEREBRAL CORTEX; DATABASES, FACTUAL; DEPRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY;

EID: 84925725593     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-159007     Document Type: Erratum

References (83)

1. Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Kokmen E, Kondo K, Mortimer JA, Rocca WA, et al. (1991) Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20(Suppl 2), S43-S47.
2. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachman D, Farrer L (2003) Depression as a risk factor for Alzheimer disease: The MIRAGE Study. Arch Neurol 60, 753-759.
3. Speck CE, Kukull WA, Brenner DE, Bowen JD, McCormick WC, Teri L, Pfanschmidt ML, Thompson JD, Larson EB (1995) History of depression as a risk factor for Alzheimer's disease. Epidemiology 6, 366-369.
4. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ (1991) Clinical risk factors for Alzheimer's disease: A population-based case-control study. Neurology 41, 1393-1397.
5. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63, 530-538.
6. Jorm AF (2001) History of depression as a risk factor for dementia: An updated review. Aust N Z J Psychiatry 35, 776-781.
7. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T (1993) The course of geriatric depression with "reversible dementia": A controlled study. Am J Psychiatry 150, 1693-1699.
8. Reynolds CF, 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST (2011) Maintenance treatment of depression in old age: A randomized, doubleblind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 68, 51-60.
9. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
10. Petersen RC (2000) Mild cognitive impairment: Transition between aging and Alzheimer's disease. Neurologia 15, 93-101.
11. Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA (2006) Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline. Neurology 67, 441-445.
12. Polyakova M, Sonnabend N, Sander C, Mergl R, Schroeter ML, Schroeder J, Schonknecht P (2014) Prevalence of minor depression in elderly persons with and without mild cognitive impairment: A systematic review. J Affect Disord 152-154 28-38.
13. Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ (2009) Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study. Neurology 73, 754-760.
14. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA 288, 1475-1483.
15. Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: The role of depression and apathy. J Alzheimers Dis 20, 175-183.
16. Dotson VM, Beydoun MA, Zonderman AB (2010) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75, 27-34.
17. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Haroutunian V (2006) Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 63, 161-167.
18. Butters MA, Klunk WE, Mathis CA, Price JC, Ziolko SK, Hoge JA, Tsopelas ND, Lopresti BJ, Reynolds CF, 3rd, DeKosky ST, Meltzer CC (2008) Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 22, 261-268.
19. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10, 24-35.
20. Wu KY, Hsiao IT, Chen CS, Chen CH, Hsieh CJ, Wai YY, Chang CJ, Tseng HJ, Yen TC, Liu CY, Lin KJ (2014) Increased brain amyloid deposition in patients with a lifetime history of major depression: Evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. Eur J Nucl Med Mol Imaging 41, 714-722.
21. Lavretsky H, Siddarth P, Kepe V, Ercoli LM, Miller KJ, Burggren AC, Bookheimer SY, Huang SC, Barrio JR, Small GW (2009) Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. Am J Geriatr Psychiatry 17, 493-502.
22. Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW, Alzheimer's Disease NeuroImaging I (2011) Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain 134, 1077-1088.
23. Alzheimer's Disease Neuroimaging Initative (2014) ADNI Website, http://adni.loni.usc.edu
24. Alzheimer's Disease Neuroimaging Initiative (2010) ADNI General Procedures Manual, http://adni.loni.usc.edu/wp-content/ uploads/2010/09/ADNI-GeneralProceduresManual.pdf
25. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
26. Wechsler D (1945) Wechsler memory scale.
27. Morris JC (1997) Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 9(Suppl 1), 173-176; discussion 177-178.
28. Alzheimer's Disease Neuroimaging Initiative (2008) ADNI 2 Procedures Manual, http://adni.loni.usc.edu/wp-content/uploads/2008/07/adni2-procedures-manual.pdf
29. Alzheimer's Disease Neuroimaging Initiative (2008) ADNI GO Procedures Manual, http://adni.loni.usc.edu/wp-content/uploads/2008/07/ADNI-GO-Procedures-Manual-06102011.pdf
30. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S (1982) Measurement of functional activities in older adults in the community. J Gerontol 37, 323-329.
31. Yesavage JA (1988) Geriatric Depression Scale. Psychopharmacol Bull 24, 709-711.
32. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314.
33. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488.
34. Alzheimer's Disease Neuroimaging Initiative (2012) ADNI Procedure Manual-Alzheimer's Disease, http://www.adniinfo.org/Scientists/Pdfs/adniproceduresmanual12.pdf
35. Alzheimer's Disease Neuroimaging Initiative (2014) ADNI Study Documents, http://adni.loni.usc.edu/methods/documents/
36. Alzheimer's Disease Neuroimaging Initiative (2014) ADNI-AV45-Methods-JagustLab-04.29.14.pdf, http://adni.bitbucket.org/ucberkeleyav45.html
37. Alzheimer's Disease Neuroimaging Initiative (2011) ADNI 2 PET Technical Procedures Manual AV-45, http://adni.loni.usc.edu/wp-content/uploads/2010/05/ADNI2-PET-Tech-Manual-0142011.pdf
38. Alzheimer's Disease Neuroimaging Initiative (2011) ADNI-GO PET Technical Procedures Manual AV-45 & FDG, http://adni.loni.usc.edu/wp-content/uploads/2010/05/ADNIGO-PET-Tech-Manual-01142011.pdf
39. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNIMRI single-subject brain. Neuroimage 15, 273-289.
40. Madsen K, Hasselbalch BJ, Frederiksen KS, Haahr ME, Gade A, Law I, Price JC, Knudsen GM, Kessing LV, Hasselbalch SG (2012) Lack of association between prior depressive episodes and cerebral [11C]PiB binding. Neurobiol Aging 33, 2334-2342.
41. Alexopoulos GS (2003) Vascular disease, depression, and dementia. J Am Geriatr Soc 51, 1178-1180.
42. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) 'Vascular depression' hypothesis. Arch Gen Psychiatry 54, 915-922.
43. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM (2007) Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci U S A 104, 10673-10678.
44. Byers AL, Yaffe K (2011) Depression and risk of developing dementia. Nat Rev Neurol 7, 323-331.
45. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26, 9047-9056.
46. Hurley LL, TizabiY(2013) Neuroinflammation, neurodegeneration, and depression. Neurotox Res 23, 131-144.
47. Reale M, Brenner T, Greig NH, Inestrosa N, Paleacu D (2010) Neuroinflammation, AD, and Dementia. Int J Alzheimers Dis 2010, Article ID 974026, 2 pages, 2010. doi:10.4061/2010/974026
48. Leonard BE (2007) Inflammation, depression and dementia: Are they connected? Neurochem Res 32, 1749-1756.
49. Bussiere T, Friend PD, Sadeghi N, Wicinski B, Lin GI, Bouras C, Giannakopoulos P, Robakis NK, Morrison JH, Perl DP, Hof PR (2002) Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 112, 75-91.
50. Braak H, Braak E (1997) Staging of Alzheimer-related cortical destruction. Int Psychogeriatr 9(Suppl 1), 257-261; discussion 269-272.
51. Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57, 925-935.
52. Bordji K, Becerril-Ortega J, Buisson A (2011) Synapses, NMDA receptor activity and neuronal Abeta production in Alzheimer's disease. Rev Neurosci 22, 285-294.
53. Piccinni A, Veltri A, Baroni S, Marazziti D, dell'Osso L (2014) Is there a role for β-amyloid in depression? Clin Neuropsychiatry 11, 76-85.
54. Galynker II, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D (1998) Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 39, 608-612.
55. Liao Y, Huang X, Wu Q, Yang C, Kuang W, Du M, Lui S, Yue Q, Chan RC, Kemp GJ, Gong Q (2013) Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci 38, 49-56.
56. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S (2004) Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 22, 409-418.
57. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46, 243-250.
58. Levesque J, Eugene F, Joanette Y, Paquette V, Mensour B, Beaudoin G, Leroux JM, Bourgouin P, Beauregard M (2003) Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 53, 502-510.
59. Koenigs M, Grafman J (2009) The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 201, 239-243.
60. Koenigs M, Huey ED, Calamia M, Raymont V, Tranel D, Grafman J (2008) Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J Neurosci 28, 12341-12348.
61. Graff-Guerrero A, Gonzalez-Olvera J, Mendoza-Espinosa Y, Vaugier V, Garcia-Reyna JC (2004) Correlation between cerebral blood flow and items of the Hamilton Rating Scale for Depression in antidepressant-naive patients. J Affect Disord 80, 55-63.
62. Hoffer ZS, Allen SL, Mathews M (2007) Treatment of psychiatric symptoms associated with a frontal lobe tumor through surgical resection. Am J Psychiatry 164, 877-882.
63. Cummings JL (1993) Frontal-subcortical circuits and human behavior. Arch Neurol 50, 873-880.
64. Shinagawa S (2013) Phenotypic variety in the presentation of frontotemporal lobar degeneration. Int Rev Psychiatry 25, 138-144.
65. Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, Gabrieli JD, Pizzagalli DA (2015) Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biol Psychiatry 77, 285-294.
66. Clark L, Manes F, Antoun N, Sahakian BJ, Robbins TW (2003) The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage. Neuropsychologia 41, 1474-1483.
67. Aron AR, Robbins TW, Poldrack RA (2004) Inhibition and the right inferior frontal cortex. Trends Cogn Sci 8, 170-177.
68. Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, Niehaus L, Boeker H, Northoff G (2008) Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: An fMRI study in severe major depressive disorder. Biol Psychiatry 63, 369-376.
69. Almeida OP, Burton EJ, Ferrier N, McKeith IG, O'Brien JT (2003) Depression with late onset is associated with right frontal lobe atrophy. Psychol Med 33, 675-681.
70. Marangell LB, Martinez M, Jurdi RA, Zboyan H (2007) Neurostimulation therapies in depression: A review of new modalities. Acta Psychiatr Scand 116, 174-181.
71. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA (2010) Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Arch Gen Psychiatry 67, 507-516.
72. Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P (2012) Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry 200, 52-59.
73. Bermpohl F, Fregni F, Boggio PS, Thut G, Northoff G, Otachi PT, Rigonatti SP, Marcolin MA, Pascual-Leone A (2006) Effect of low-frequency transcranial magnetic stimulation on an affective go/no-go task in patients with major depression: Role of stimulation site and depression severity. Psychiatry Res 141, 1-13.
74. Geerlings SW, Beekman AT, Deeg DJ, Van Tilburg W (2000) Physical health and the onset and persistence of depression in older adults: An eight-wave prospective community-based study. Psychol Med 30, 369-380.
75. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, Santamato A, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V (2010) Late-life depression, mild cognitive impairment, and dementia: Possible continuum? Am J Geriatr Psychiatry 18, 98-116.
76. Shorter E (2009) Before Prozac: The Troubled History of Mood Disorders in Psychiatry, Oxford University Press, New York.
77. Levine H 3rd,Walker LC (2010) Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging 31, 542-548.
78. Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, De Felice FG, Ferreira ST (2013) Amyloid-beta oligomers link depressive-like behavior and cognitive deficits in mice. Mol Psychiatry 18, 1053-1054.
79. Colaianna M, Tucci P, Zotti M, Morgese MG, Schiavone S, Govoni S, Cuomo V, Trabace L (2010) Soluble beta amyloid(1-42): A critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol 159, 1704-1715.
80. Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, Ficker WD, Yan P, Xiong C, Frederiksen C, Grzelak MV, Chott R, Bateman RJ, Morris JC, Mintun MA, Lee JM, Cirrito JR (2014) An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med 6, 236re234.
81. Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW, Alzheimer's Disease Neuroimaging I (2009) MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 132, 1067-1077.
82. Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Guzman VA, Meier IB, Zimmerman ME, Brickman AM, Alzheimer's Disease Neuroimaging I (2013) White matter hyperintensities and cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol 70, 455-461.
83. rd (2013) Late-life depression and risk of vascular dementia and Alzheimer's disease: Systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 202, 329-335.